LONGITUDINAL STUDY OF OSTEOPOROSIS IMPERFECTA
骨质疏松症不全症的纵向研究
基本信息
- 批准号:8356784
- 负责人:
- 金额:$ 1.15万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-12-01 至 2011-11-30
- 项目状态:已结题
- 来源:
- 关键词:BaltimoreCaringClinical ResearchClinical TrialsCollagen Type ICommitData AnalysesData CollectionDevelopmentDevicesDiseaseDisease ProgressionEnrollmentEthnic OriginFloridaFoundationsFractureFundingGenotypeGrantHealth SciencesIndividualInstitutesInvestigationLinkLongitudinal StudiesMarylandMedicalMedicineModelingMorbidity - disease rateMulticenter StudiesNational Center for Research ResourcesNatural HistoryOregonOsteogenesis ImperfectaOsteoporosisOutcomePainParticipantPatientsPharmaceutical PreparationsPrevalencePrincipal InvestigatorProtocols documentationRare DiseasesResearchResearch InfrastructureResourcesSafetySeverity of illnessSiteSourceSurgical ManagementTexasTherapeutic InterventionTreatment outcomeUnited States National Institutes of HealthUniversitiesbonecohortcollegecostimprovedmortalitymultidisciplinarynovel therapeuticsresearch study
项目摘要
This subproject is one of many research subprojects utilizing the resources
provided by a Center grant funded by NIH/NCRR. Primary support for the subproject
and the subproject's principal investigator may have been provided by other sources,
including other NIH sources. The Total Cost listed for the subproject likely
represents the estimated amount of Center infrastructure utilized by the subproject,
not direct funding provided by the NCRR grant to the subproject or subproject staff.
ABSTRACT
Osteogenesis Imperfecta (OI) is a rare disorder of increased bone fragility that is most often due to abnormalities in type I collagen. Because of the rarity of this disorder and the pan-ethnicity of the disorder, there is no geographic clustering of individuals with OI and therefore there are no centers that have sufficient numbers of patients with OI to perform adequately powered studies alone. To date, large clinical research studies on the natural history or management of OI have not been performed.
The majority of advances in medical care in the last few decades are informed by large, multicenter studies of natural history, drugs or devices for particular disorders. For rare disorders, the multicenter model is critical for obtaining enough information on enough individuals for a study to be valid. Toward this end, the OI Foundation has committed resources to the development of linked clinical research centers. There will be three centers in the first year of funding (Baylor College of Medicine, Houston, Texas; The Kennedy-Kreiger Institute, Baltimore, Maryland and Oregon Health Science University, Portland, Oregon) and a data collection and analysis center (University of South Florida College of Medicine, Tampa, Florida). It is expected that each center will enroll a minimum of 40 patients in the first 12 months of funding. We anticipate that additional centers will be added in subsequent years with around two dozen participant sites at year five of the LCRC initiative.
The initial focus will be on performing a natural history study of OI and it is anticipated that from this, focused research questions will be developed to look at outcomes of medical and surgical management, including clinical trials of new therapeutic articles.
I. HYPOTHESIS
A longitudinal multidisciplinary investigation of the natural history, morbidity, and mortality in people with osteogenesis imperfecta will improve treatment and outcome of this devastating disorder.
II. SPECIFIC AIMS
The objective of this protocol is to conduct a longitudinal multidisciplinary investigation of the natural history, current therapeutic interventions, morbidity, and mortality in people with OI.
The research questions are:
a. In the longitudinal cohort, what is the prevalence of specific morbid indicators of disease severity, including fractures, pain, and functionality/mobility, as well as case-fatality associated with the various forms of OI?
b. What is the relationship between various genotype and disease severity and progression?
c. What is the safety and efficacy of currently used and new OI therapies?
这个子项目是许多利用资源的研究子项目之一
由NIH/NCRR资助的中心拨款提供。子项目的主要支持
而子项目的主要调查员可能是由其他来源提供的,
包括其他NIH来源。 列出的子项目总成本可能
代表子项目使用的中心基础设施的估计数量,
而不是由NCRR赠款提供给子项目或子项目工作人员的直接资金。
摘要
成骨不全(OI)是一种罕见的骨脆性增加的疾病,最常见的是由于I型胶原蛋白异常。 由于这种疾病的罕见性和疾病的泛种族性,OI个体没有地理聚集性,因此没有中心有足够数量的OI患者单独进行充分的把握度研究。 迄今为止,尚未进行关于OI自然史或管理的大型临床研究。
在过去的几十年里,医疗保健的大多数进步都是由针对特定疾病的自然史、药物或设备的大型多中心研究提供信息的。 对于罕见疾病,多中心模型对于获得足够个体的足够信息以使研究有效至关重要。 为此,OI基金会已投入资源,以发展相关的临床研究中心。 在第一年的资助中,将有三个中心(贝勒医学院,休斯顿,得克萨斯州;该研究所,巴尔的摩,马里兰州和俄勒冈州健康科学大学,波特兰,俄勒冈州)和一个数据收集和分析中心(南佛罗里达大学医学院,坦帕,佛罗里达)。 预计每个中心将在资助的前12个月招募至少40名患者。 我们预计,在LCRC计划的第五年,将在随后的几年中增加更多的中心,大约有24个参与中心。
最初的重点将是进行OI的自然史研究,预计将由此开发重点研究问题,以观察医疗和手术管理的结果,包括新治疗文章的临床试验。
I. 假设
一个纵向的多学科调查的自然史,发病率和死亡率的人与成骨不全将改善治疗和这种毁灭性的疾病的结果。
二. 具体目标
本方案的目的是对OI患者的自然史、当前治疗干预、发病率和死亡率进行纵向多学科研究。
研究问题是:
a. 在纵向队列中,疾病严重程度的特定病理指标的患病率如何,包括骨折、疼痛和功能/活动性,以及与各种形式的OI相关的病死率?
B. 不同基因型与疾病严重程度和进展有何关系?
C. 目前使用的和新的OI疗法的安全性和有效性如何?
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
VERNON R SUTTON其他文献
VERNON R SUTTON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('VERNON R SUTTON', 18)}}的其他基金
Molecular Mechanism of long Noncoding RNAs in Phenylketonuria
长非编码RNA在苯丙酮尿症中的分子机制
- 批准号:
10562363 - 财政年份:2023
- 资助金额:
$ 1.15万 - 项目类别:
CLINICAL PHENOTYPE OF IMPRINTED GENES ON CHROMOSOME 14
14号染色体印记基因的临床表型
- 批准号:
7374930 - 财政年份:2005
- 资助金额:
$ 1.15万 - 项目类别:
CLINICAL PHENOTYPE OF IMPRINTED GENES ON CHROMOSOME 14
14 号染色体印记基因的临床表型
- 批准号:
7206726 - 财政年份:2004
- 资助金额:
$ 1.15万 - 项目类别:
Clinical Phenotype of Imprinted Genes on Chromosome 14
14 号染色体印记基因的临床表型
- 批准号:
7041653 - 财政年份:2003
- 资助金额:
$ 1.15万 - 项目类别:
Clinical Phenotype of Imprinted Genes of Chromosome 14
14号染色体印记基因的临床表型
- 批准号:
6760205 - 财政年份:2001
- 资助金额:
$ 1.15万 - 项目类别:
Clinical Phenotype of Imprinted Genes of Chromosome 14
14号染色体印记基因的临床表型
- 批准号:
6919231 - 财政年份:2001
- 资助金额:
$ 1.15万 - 项目类别:
Clinical Phenotype of Imprinted Genes of Chromosome 14
14号染色体印记基因的临床表型
- 批准号:
6536394 - 财政年份:2001
- 资助金额:
$ 1.15万 - 项目类别:
Clinical Phenotype of Imprinted Genes of Chromosome 14
14号染色体印记基因的临床表型
- 批准号:
6638047 - 财政年份:2001
- 资助金额:
$ 1.15万 - 项目类别:
Clinical Phenotype of Imprinted Genes of Chromosome 14
14号染色体印记基因的临床表型
- 批准号:
6360010 - 财政年份:2001
- 资助金额:
$ 1.15万 - 项目类别:
相似海外基金
A self-guided and monitored innovative AI-driven parental support intervention (mobile app), for families caring for a young one that self-harms: feasibility study
一种自我指导和监控的创新型人工智能驱动的家长支持干预措施(移动应用程序),适用于照顾自残儿童的家庭:可行性研究
- 批准号:
10101171 - 财政年份:2024
- 资助金额:
$ 1.15万 - 项目类别:
Collaborative R&D
Caring Communities 1800-present: Rethinking Children's Social Care
关爱社区 1800 年至今:重新思考儿童的社会关怀
- 批准号:
MR/X034968/1 - 财政年份:2024
- 资助金额:
$ 1.15万 - 项目类别:
Fellowship
Conference: Caring for the Future: Empathy in Engineering Education
会议:关爱未来:工程教育中的同理心
- 批准号:
2418876 - 财政年份:2024
- 资助金额:
$ 1.15万 - 项目类别:
Standard Grant
Who is Caring for the Caregiver? Understanding Quality of Life and Mental Health Outcomes in Caregivers of Persons with Brain Injury
谁在照顾看护者?
- 批准号:
492369 - 财政年份:2023
- 资助金额:
$ 1.15万 - 项目类别:
Operating Grants
When caring ends: Understanding and supporting informal care trajectories
当护理结束时:理解和支持非正式护理轨迹
- 批准号:
LP220100209 - 财政年份:2023
- 资助金额:
$ 1.15万 - 项目类别:
Linkage Projects
Caring for Providers to Improve Patient Experience (CPIPE) Study
关爱医疗服务提供者以改善患者体验 (CPIPE) 研究
- 批准号:
10556284 - 财政年份:2023
- 资助金额:
$ 1.15万 - 项目类别:
Intergenerational conversations in contemporary performance: conflict, caring and the earth crisis
当代表演中的代际对话:冲突、关怀和地球危机
- 批准号:
2887471 - 财政年份:2023
- 资助金额:
$ 1.15万 - 项目类别:
Studentship
Evaluation of the Caring Letters Suicide Prevention Intervention after Removal of an Electronic Health Record Flag for Suicide Risk: An Effectiveness-Implementation Hybrid Type 2 Trial
移除电子健康记录自杀风险标记后关怀信自杀预防干预的评估:有效性-实施混合 2 型试验
- 批准号:
10753299 - 财政年份:2023
- 资助金额:
$ 1.15万 - 项目类别:
Co-creating a new model of long-term care home for older adults experiencing homelessness: Long-term Caring
为无家可归的老年人共同打造长期护理院新模式:长期关怀
- 批准号:
490004 - 财政年份:2023
- 资助金额:
$ 1.15万 - 项目类别:
Operating Grants
Developing cultural competency training for app-based peer supporters caring for Canadian public safety personnel
为照顾加拿大公共安全人员的基于应用程序的同伴支持者开发文化能力培训
- 批准号:
488193 - 财政年份:2023
- 资助金额:
$ 1.15万 - 项目类别:
Operating Grants